残粒脂蛋白对循环内皮祖细胞血管新生的影响
|
摘要
背景与目的：内皮祖细胞(Endothelial Progenitor Cells, EPCs)的数量和功能与血管内皮功能明确相关。细胞复制性衰老是指细胞失去分化能力,同时发生相应形态学改变和其它功能障碍。危险因素通过氧化机制加速EPCs的衰老进程。残粒脂蛋白(Remnant lipoproteins, RLPs)可通过氧化机制直接导致血管内皮舒张功能损害和成熟内皮细胞分泌功能的异常,但是还不清楚RLPs是否还影响EPCs衰老及其功能。本研究拟观察RLPs对EPCs衰老、增殖、迁移、粘附和体外血管新生能力的影响。
方法：
采用已建立的高脂餐方案：总热量为800千卡(脂肪50克、蛋白质28克、碳水化合物60克),采集高甘油三酯血症患者脂餐后4小时EDTA抗凝静脉血标本。应用免疫亲和层析法和密度梯度超速离心技术分离人血浆RLPs, BCA法测定RLPs的蛋白含量。密度梯度离心法分离人外周血的单个核细胞,利用添加生长因子的M 199条件培养基诱导单个核细胞贴壁向EPCs分化。流式细胞仪、双荧光染色、直接免疫荧光染色和普通免疫细胞化学染色鉴定EPCs。
1)将不同浓度(0-200μg/mL)的RLPs加入第10天的EPCs,分别培养6、12、24及48小时。采用衰老相关的p-半乳糖苷酶(senescence-associatedβ-galactosidase, SA-β-Gal)染色技术,在PH6的条件下,计数强SA-β-gal活性的EPCs,获取RLPs影响EPCs衰老进程的最大效应浓度(CR)和最佳干预时间(TR)。
2)将培养第10天EPCs以添加CR浓度RLPs的M199条件培养液培养TR时间,再加入不同浓度(0.01-10μmol/L)的阿托伐他汀(Atorvastatin,ATR),分别培养6、12、24及48小时。采用SA-β-gal染色技术,在PH6的条件下,计数强SA-β-gal活性的EPCs,获取ATR影响EPCs衰老进程的最大效应浓度(CA)和最佳干预时间(TA)。
3)分为空白对照组、RLPs刺激组、ATR干预组和RLPs刺激+ATR干预组。将浓度为CR的RLPs、浓度为CA的ATR和对照物于细胞培养第10天加入EPCs,分别作用相应时间。采用SA-β-gal染色技术,在PH6的条件下,计数强SA-β-gal活性的EPCs,检测各干预措施对EPCs衰老的影响。
4)观察RLPs对EPCs功能的影响
分为空白对照组、RLPs刺激组、ATR干预组和RLPs刺激+ATR干预组。将浓度为CR的RLPs、浓度为CA的ATR和对照物于细胞培养第10天加入EPCs,分别作用相应时间。①改良的Boyden小室评价细胞迁移能力。②粘附能力测定实验评价细胞粘附能力。③MTT比色法评价细胞增殖能力。④Matrigel成血管网实验评价EPCs在体外的血管新生能力。
结果：
(1)外周血单个核细胞用添加生长因子的M199条件培养基培养可诱导分化成EPCs,具备典型的形态学和表型特征；
(2)从高甘油三酯血症患者静脉血中制得RLPs,经BCA法测定的RLPs蛋白浓度值为4.28±0.36mg/mL;
(3) RLPs的最大效应浓度为100μg/mL,最佳干预时间为24小时；ATR的最大效应浓度为1.0μmol/L,最佳干预时间为24小时；
(4) RLPs刺激能使EPCs的SA-β-Gal活性增加,EPCs衰老细胞数增加,其迁移、粘附、增殖和形成微血管网的能力显著降低；
(5)ATR治疗可以降低EPCs的SA-β-Gal活性,显著减少EPCs衰老细胞数,增强其迁移、粘附、增殖和形成微血管网的能力。
结论：RLPs可以导致EPCs衰老并抑制其血管新生的相关功能,ATR治疗可以改善RLPs对EPCs的上述负面影响。
背景与目的：裸鼠后肢缺血模型是目前国际上最常采用的用于评价EPCs移植治疗效果的实验动物模型。采用裸鼠后肢缺血模型,通过移植DAPI标记的EPCs,并运用免疫组化技术、细胞衰老生物标记染色技术和激光多普勒血流成像技术,观察RLPs对EPCs移植后裸鼠缺血后肢血运重建的影响。
方法：
参照Heeschen等的方法(Circulation,2004;109:1615-22),应用8-10周龄BALB/c雄性裸鼠建立后肢缺血裸鼠模型,缺血手术24小时后,以PBS液作对照,由尾静脉注入体外扩增培养10天且经DAPI荧光标记的EPCs至裸鼠体内。于EPCs移植第1天开始,每间隔48小时经由尾静脉注入RLPs或对照物；同时根据ATR应用情况,将裸鼠分为：对照组、RLPs刺激组、ATR干预组、RLPs刺激+ATR干预组。激光多普勒血流扫描仪监测后肢的血液灌流情况。21天后,处死裸鼠,取缺血后肢与正常后肢腓肠肌做病理切片。免疫组化法检测缺血组织的新生微血管密度和EPCs的组织分布情况。采用SA-β-gal染色技术,在PH6的条件下,计数强SA-β-gal活性的血管数目。
结果：
(1)成功建立裸鼠后肢缺血模型,缺血后肢末梢循环、运动功能、血流灌注情况随时间发生规律改变,组织病理学改变符合缺血特征；
(2) EPCs移植可以显著降低缺血后肢的伤残率；
(3) RLPs刺激组的EPCs组织分布数、新生毛细血管密度和缺血后肢血流灌注要显著低于其他各组,可以观察到新生血管的衰老现象；
(4)ATR治疗组的EPCs组织分布数、新生毛细血管密度和缺血后肢血流灌注要显著高于其他各组。
结论：RLPs通过刺激EPCs衰老而抑制其在体内的血管新生能力,ATR治疗可以改善EPCs受损的血管新生能力。
背景与目的：微小RNA(microRNA, miRNA)是新近证明的一类高度保守的、内源性非蛋白编码的长度约为20-24个核苷酸的小分子RNA,参与调节血管内皮细胞或胚胎干细胞的血管新生,参与调控细胞衰老。通过对RLPs干预体外培养EPCs的研究,利用miRNA芯片技术检测相关miRNA的改变情况,以初步了解miRNA是否参与调控RLPs对EPCs血管新生的影响。
方法：
取培养第10天EPCs,分为RLPs干预组和对照组,采用Agilent的人microRNA寡核苷酸基因芯片寻找显著差异表达的miRNA,构建RLPs干预组和对照组的miRNA表达谱：用mirVana RNA Isolation Kit提取两组EPCs的总RNA并进行纯化；使用Nanodrop分光光度计(NP-1000)测定RNA在260nm和280nm波长的吸收值,计算样本总RNA浓度并评估纯度；采用Agilent RNA 6000 Nano Assay检测RNA纯度及完整性；采用Agilent's miRNA Complete Labeling and Hyb Kit进行：miRNA荧光标记和芯片杂交；采用Agilent's Gene Expression Wash Buffer Kit进行杂交芯片的洗脱；使用Agilent Microarray Scanner扫描芯片的荧光强度并借助Agilent Feature Extraction Software提取原始数据进行分析运算,筛选两组间差异表达显著的miRNA。
结果：
与对照组相比,EPCs经RLPs干预后显著异常表达的miRNA共有4个,显著上调表达miRNA有3个,分别为：hsa-miR-148b*、hsa-miR-155*和hsa-miR-513c;一个显著下调的miRNA,即hsa-miR-574-3p。
结论：miRNA可能参与调控RLPs对EPCs血管新生的影响。
Background and Objective:Remnant lipoproteins (RLPs) are closely associated with coronary heart disease and can induce endothelial dysfunction through oxidative mechanisms. Many risk factors accelerate the onset of endothelial progenitor cells (EPCs) senescence via increased oxidative stress. In this study, we investigated the effect of RLPs on EPCs senescence and function.
Methods:RLPs were isolated from postprandial plasma of hypertriglyceridemic patients by use of the immunoaffinity gel mixture of anti-apoA-1 and anti-apoB-100 monoclonal antibodies. The mononuclear cells were isolated by Ficoll density gradient centrifugation. The isolated cells were suspended in Medium 199 supplement with 20% fetal blood serum and bovine pituitary extract for culturing, differentiating and proliferating. The expressions of specific antigens on cell surface, such as CD133、KDR、CD34、CD31 and vWF were analyzed by immunocytochemistry on day 10. To assess the onset of senescence, SA-β-gal activity was measured. The numbers of SA-β-gal positive cells were counted manually in each sample under bright field illumination. Modified Boyden chamber assay and MTT assay was used to measure the migration and proliferation function of EPCs.The adhesion assay was performed by replating on fibronectin-coated dishes, then adherent cells were counted. Matrigel Network Formation Assay was performed by replating on Matrigel-coated dishes, then the number of closed loops formed by capillary tubes network was counted.
Results:peripheral blood mononuclear cells cultivated with M199 supplement with growth factors generated EPCs as expected, which were characterized by typical morphology and phenotype. EPCs became senescent as determined by senescence-associated acidicβ-galactosidase (SA-β-Gal) staining after ex vivo cultivation without any stimulation. Co-incubation with RLPs accelerated the increase in SA-β-Gal-positive EPCs. The acceleration of RLPs-induced EPCs senescence occurred dose-dependently with a maximal effect when EPCs were treated with RLPs at 100μg/mL (P<0.01). RLPs decreased adhesion, migration and proliferation capacities of EPCs as assessed by adherence to fibronectin, modified Boyden chamber technique and MTT assay (P<0.01), respectively. Moreover RLPs suppressed capillary-like tube formation on Matrigel for all cells tested. However, RLPs-induced EPCs senescence and dysfunction were significantly inhibited by treatment of atorvastatin (ATR,1.0μmol/L)(P<0.01).
Conclusions:RLPs accelerate the onset of EPCs senescence via increased oxidative stress, accompanying with the impaired adhesion, migration, proliferation and suppressed capillary-like tube formation capacity. ATR prevents RLPs-induced senescence and EPCs dysfunction.
Background and Objective:Hindlimb ischemia model is the widely used animal model, for it involved in the study of angiosclerosis and embolism in lower limb. Recentely, it becames an original tendency that encouraging the neovascularization by EPCs transplantation in animal hindlimb ischemia model. In this study, we investigated the effects of RLPs on therapeutic angiogenesis of circulating endothelial progenitor cells transplanted in hindlimb-ischemic nude mouse.
Methods:8-10 weeks old BALB/c male nude mice were operated according to Heeschen's methods(Circulation,2004; 109:1615-22) to obtain hind limb ischemia model.One day after surgery, 1×106 of DAPI labeled EPCs in 200μL of M199 medium were injected into the caudal vein of mice. A laser Doppler perfusion imager (Moor Instruments), which maps tissue blood flow by the shift in the laser light frequency, was used for serial noninvasive physiological evaluation of neovascularization. Each mouse was followed by serial recording of surface blood flow of hind limb on days 0,3,7,14, and 21. Tissue capillary density was determined as a histological evaluation of neovascularization. To assess the onset of senescence, SA-β-gal activity was measured. The numbers of SA-β-gal positive cells and capillaries were counted manually in each sample under bright field illumination.
Results::We establish nude mouse hindlimb ischemia mode with obvious ischemia in mouse's hindlimb. EPCs transplantation significantly reduce foot necrosis and auto-amputation. Administration of EPCs treated with ATR resulted in a significantly lower rate of limb loss (necrosis of tissue above knee or autoamputation) compared with EPCs treated with RLPs and with control (P<0.01). Serial analysis of laser Doppler perfusion imaging revealed a greater increase of limb perfusion in the ischemic limb of mice injected with EPCs that were treated with ATR than with RLPs(P<0.01). Administration of EPCs treated with ATR increased capillary density of ischemic skeletal muscle compared with EPCs that were treated with RLPs(P<0.01).
Conclusions:RLPs accelerate the onset of EPCs senescence and reduce therapeutic angiogenesis of circulating EPCs transplanted in hindlimb-ischemic nude mouse. ATR improves the angiogenesis ability of these EPCs.
Background and Objective:MicroRNAs (miRNAs) are small (18-24nt) non-coding RNAs that regulate a large variety of cellular processes including differentiation, apoptosis, proliferation and neovascularization. We investigated the possible mechanism of effects of remnant lipoproteins on angiogenesis of circulating endothelial progenitor cells using an oligonucleotide microchip for microRNA profiling.
Methods:After 10 days of culture, EPCs were treated with/ without RLPs,the later were served as control. An oligonucleotide microchip was used to find miRNAs that were differential expressed. Total RNA was extracted using mirVana RNA Isolation Kit for miRNA microarray. Assess the purity of the RNA adopting Agilent RNA 6000 Nano Assay. Between two groups of the fingerprints, Agilent Microarray Scanner and Agilent Feature Extraction Softwarewas performed to screen the markedly differentially expressed genes.
Results:Four miRNAs differentially expressed between these two groups were detected. Three are upregulated:hsa-miR-148b*、hsa-miR-155、and hsa-miR-513c, One is downregulated, that is hsa-miR-574-3p (RLPs treated vs. control).
Conclusions:MiRNAs may regulate the effect of remnant lipop-roteins on angiogenesis of circulating endothelial progenitor cells.
方法：
采用已建立的高脂餐方案：总热量为800千卡(脂肪50克、蛋白质28克、碳水化合物60克),采集高甘油三酯血症患者脂餐后4小时EDTA抗凝静脉血标本。应用免疫亲和层析法和密度梯度超速离心技术分离人血浆RLPs, BCA法测定RLPs的蛋白含量。密度梯度离心法分离人外周血的单个核细胞,利用添加生长因子的M 199条件培养基诱导单个核细胞贴壁向EPCs分化。流式细胞仪、双荧光染色、直接免疫荧光染色和普通免疫细胞化学染色鉴定EPCs。
1)将不同浓度(0-200μg/mL)的RLPs加入第10天的EPCs,分别培养6、12、24及48小时。采用衰老相关的p-半乳糖苷酶(senescence-associatedβ-galactosidase, SA-β-Gal)染色技术,在PH6的条件下,计数强SA-β-gal活性的EPCs,获取RLPs影响EPCs衰老进程的最大效应浓度(CR)和最佳干预时间(TR)。
2)将培养第10天EPCs以添加CR浓度RLPs的M199条件培养液培养TR时间,再加入不同浓度(0.01-10μmol/L)的阿托伐他汀(Atorvastatin,ATR),分别培养6、12、24及48小时。采用SA-β-gal染色技术,在PH6的条件下,计数强SA-β-gal活性的EPCs,获取ATR影响EPCs衰老进程的最大效应浓度(CA)和最佳干预时间(TA)。
3)分为空白对照组、RLPs刺激组、ATR干预组和RLPs刺激+ATR干预组。将浓度为CR的RLPs、浓度为CA的ATR和对照物于细胞培养第10天加入EPCs,分别作用相应时间。采用SA-β-gal染色技术,在PH6的条件下,计数强SA-β-gal活性的EPCs,检测各干预措施对EPCs衰老的影响。
4)观察RLPs对EPCs功能的影响
分为空白对照组、RLPs刺激组、ATR干预组和RLPs刺激+ATR干预组。将浓度为CR的RLPs、浓度为CA的ATR和对照物于细胞培养第10天加入EPCs,分别作用相应时间。①改良的Boyden小室评价细胞迁移能力。②粘附能力测定实验评价细胞粘附能力。③MTT比色法评价细胞增殖能力。④Matrigel成血管网实验评价EPCs在体外的血管新生能力。
结果：
(1)外周血单个核细胞用添加生长因子的M199条件培养基培养可诱导分化成EPCs,具备典型的形态学和表型特征；
(2)从高甘油三酯血症患者静脉血中制得RLPs,经BCA法测定的RLPs蛋白浓度值为4.28±0.36mg/mL;
(3) RLPs的最大效应浓度为100μg/mL,最佳干预时间为24小时；ATR的最大效应浓度为1.0μmol/L,最佳干预时间为24小时；
(4) RLPs刺激能使EPCs的SA-β-Gal活性增加,EPCs衰老细胞数增加,其迁移、粘附、增殖和形成微血管网的能力显著降低；
(5)ATR治疗可以降低EPCs的SA-β-Gal活性,显著减少EPCs衰老细胞数,增强其迁移、粘附、增殖和形成微血管网的能力。
结论：RLPs可以导致EPCs衰老并抑制其血管新生的相关功能,ATR治疗可以改善RLPs对EPCs的上述负面影响。
背景与目的：裸鼠后肢缺血模型是目前国际上最常采用的用于评价EPCs移植治疗效果的实验动物模型。采用裸鼠后肢缺血模型,通过移植DAPI标记的EPCs,并运用免疫组化技术、细胞衰老生物标记染色技术和激光多普勒血流成像技术,观察RLPs对EPCs移植后裸鼠缺血后肢血运重建的影响。
方法：
参照Heeschen等的方法(Circulation,2004;109:1615-22),应用8-10周龄BALB/c雄性裸鼠建立后肢缺血裸鼠模型,缺血手术24小时后,以PBS液作对照,由尾静脉注入体外扩增培养10天且经DAPI荧光标记的EPCs至裸鼠体内。于EPCs移植第1天开始,每间隔48小时经由尾静脉注入RLPs或对照物；同时根据ATR应用情况,将裸鼠分为：对照组、RLPs刺激组、ATR干预组、RLPs刺激+ATR干预组。激光多普勒血流扫描仪监测后肢的血液灌流情况。21天后,处死裸鼠,取缺血后肢与正常后肢腓肠肌做病理切片。免疫组化法检测缺血组织的新生微血管密度和EPCs的组织分布情况。采用SA-β-gal染色技术,在PH6的条件下,计数强SA-β-gal活性的血管数目。
结果：
(1)成功建立裸鼠后肢缺血模型,缺血后肢末梢循环、运动功能、血流灌注情况随时间发生规律改变,组织病理学改变符合缺血特征；
(2) EPCs移植可以显著降低缺血后肢的伤残率；
(3) RLPs刺激组的EPCs组织分布数、新生毛细血管密度和缺血后肢血流灌注要显著低于其他各组,可以观察到新生血管的衰老现象；
(4)ATR治疗组的EPCs组织分布数、新生毛细血管密度和缺血后肢血流灌注要显著高于其他各组。
结论：RLPs通过刺激EPCs衰老而抑制其在体内的血管新生能力,ATR治疗可以改善EPCs受损的血管新生能力。
背景与目的：微小RNA(microRNA, miRNA)是新近证明的一类高度保守的、内源性非蛋白编码的长度约为20-24个核苷酸的小分子RNA,参与调节血管内皮细胞或胚胎干细胞的血管新生,参与调控细胞衰老。通过对RLPs干预体外培养EPCs的研究,利用miRNA芯片技术检测相关miRNA的改变情况,以初步了解miRNA是否参与调控RLPs对EPCs血管新生的影响。
方法：
取培养第10天EPCs,分为RLPs干预组和对照组,采用Agilent的人microRNA寡核苷酸基因芯片寻找显著差异表达的miRNA,构建RLPs干预组和对照组的miRNA表达谱：用mirVana RNA Isolation Kit提取两组EPCs的总RNA并进行纯化；使用Nanodrop分光光度计(NP-1000)测定RNA在260nm和280nm波长的吸收值,计算样本总RNA浓度并评估纯度；采用Agilent RNA 6000 Nano Assay检测RNA纯度及完整性；采用Agilent's miRNA Complete Labeling and Hyb Kit进行：miRNA荧光标记和芯片杂交；采用Agilent's Gene Expression Wash Buffer Kit进行杂交芯片的洗脱；使用Agilent Microarray Scanner扫描芯片的荧光强度并借助Agilent Feature Extraction Software提取原始数据进行分析运算,筛选两组间差异表达显著的miRNA。
结果：
与对照组相比,EPCs经RLPs干预后显著异常表达的miRNA共有4个,显著上调表达miRNA有3个,分别为：hsa-miR-148b*、hsa-miR-155*和hsa-miR-513c;一个显著下调的miRNA,即hsa-miR-574-3p。
结论：miRNA可能参与调控RLPs对EPCs血管新生的影响。
Background and Objective:Remnant lipoproteins (RLPs) are closely associated with coronary heart disease and can induce endothelial dysfunction through oxidative mechanisms. Many risk factors accelerate the onset of endothelial progenitor cells (EPCs) senescence via increased oxidative stress. In this study, we investigated the effect of RLPs on EPCs senescence and function.
Methods:RLPs were isolated from postprandial plasma of hypertriglyceridemic patients by use of the immunoaffinity gel mixture of anti-apoA-1 and anti-apoB-100 monoclonal antibodies. The mononuclear cells were isolated by Ficoll density gradient centrifugation. The isolated cells were suspended in Medium 199 supplement with 20% fetal blood serum and bovine pituitary extract for culturing, differentiating and proliferating. The expressions of specific antigens on cell surface, such as CD133、KDR、CD34、CD31 and vWF were analyzed by immunocytochemistry on day 10. To assess the onset of senescence, SA-β-gal activity was measured. The numbers of SA-β-gal positive cells were counted manually in each sample under bright field illumination. Modified Boyden chamber assay and MTT assay was used to measure the migration and proliferation function of EPCs.The adhesion assay was performed by replating on fibronectin-coated dishes, then adherent cells were counted. Matrigel Network Formation Assay was performed by replating on Matrigel-coated dishes, then the number of closed loops formed by capillary tubes network was counted.
Results:peripheral blood mononuclear cells cultivated with M199 supplement with growth factors generated EPCs as expected, which were characterized by typical morphology and phenotype. EPCs became senescent as determined by senescence-associated acidicβ-galactosidase (SA-β-Gal) staining after ex vivo cultivation without any stimulation. Co-incubation with RLPs accelerated the increase in SA-β-Gal-positive EPCs. The acceleration of RLPs-induced EPCs senescence occurred dose-dependently with a maximal effect when EPCs were treated with RLPs at 100μg/mL (P<0.01). RLPs decreased adhesion, migration and proliferation capacities of EPCs as assessed by adherence to fibronectin, modified Boyden chamber technique and MTT assay (P<0.01), respectively. Moreover RLPs suppressed capillary-like tube formation on Matrigel for all cells tested. However, RLPs-induced EPCs senescence and dysfunction were significantly inhibited by treatment of atorvastatin (ATR,1.0μmol/L)(P<0.01).
Conclusions:RLPs accelerate the onset of EPCs senescence via increased oxidative stress, accompanying with the impaired adhesion, migration, proliferation and suppressed capillary-like tube formation capacity. ATR prevents RLPs-induced senescence and EPCs dysfunction.
Background and Objective:Hindlimb ischemia model is the widely used animal model, for it involved in the study of angiosclerosis and embolism in lower limb. Recentely, it becames an original tendency that encouraging the neovascularization by EPCs transplantation in animal hindlimb ischemia model. In this study, we investigated the effects of RLPs on therapeutic angiogenesis of circulating endothelial progenitor cells transplanted in hindlimb-ischemic nude mouse.
Methods:8-10 weeks old BALB/c male nude mice were operated according to Heeschen's methods(Circulation,2004; 109:1615-22) to obtain hind limb ischemia model.One day after surgery, 1×106 of DAPI labeled EPCs in 200μL of M199 medium were injected into the caudal vein of mice. A laser Doppler perfusion imager (Moor Instruments), which maps tissue blood flow by the shift in the laser light frequency, was used for serial noninvasive physiological evaluation of neovascularization. Each mouse was followed by serial recording of surface blood flow of hind limb on days 0,3,7,14, and 21. Tissue capillary density was determined as a histological evaluation of neovascularization. To assess the onset of senescence, SA-β-gal activity was measured. The numbers of SA-β-gal positive cells and capillaries were counted manually in each sample under bright field illumination.
Results::We establish nude mouse hindlimb ischemia mode with obvious ischemia in mouse's hindlimb. EPCs transplantation significantly reduce foot necrosis and auto-amputation. Administration of EPCs treated with ATR resulted in a significantly lower rate of limb loss (necrosis of tissue above knee or autoamputation) compared with EPCs treated with RLPs and with control (P<0.01). Serial analysis of laser Doppler perfusion imaging revealed a greater increase of limb perfusion in the ischemic limb of mice injected with EPCs that were treated with ATR than with RLPs(P<0.01). Administration of EPCs treated with ATR increased capillary density of ischemic skeletal muscle compared with EPCs that were treated with RLPs(P<0.01).
Conclusions:RLPs accelerate the onset of EPCs senescence and reduce therapeutic angiogenesis of circulating EPCs transplanted in hindlimb-ischemic nude mouse. ATR improves the angiogenesis ability of these EPCs.
Background and Objective:MicroRNAs (miRNAs) are small (18-24nt) non-coding RNAs that regulate a large variety of cellular processes including differentiation, apoptosis, proliferation and neovascularization. We investigated the possible mechanism of effects of remnant lipoproteins on angiogenesis of circulating endothelial progenitor cells using an oligonucleotide microchip for microRNA profiling.
Methods:After 10 days of culture, EPCs were treated with/ without RLPs,the later were served as control. An oligonucleotide microchip was used to find miRNAs that were differential expressed. Total RNA was extracted using mirVana RNA Isolation Kit for miRNA microarray. Assess the purity of the RNA adopting Agilent RNA 6000 Nano Assay. Between two groups of the fingerprints, Agilent Microarray Scanner and Agilent Feature Extraction Softwarewas performed to screen the markedly differentially expressed genes.
Results:Four miRNAs differentially expressed between these two groups were detected. Three are upregulated:hsa-miR-148b*、hsa-miR-155、and hsa-miR-513c, One is downregulated, that is hsa-miR-574-3p (RLPs treated vs. control).
Conclusions:MiRNAs may regulate the effect of remnant lipop-roteins on angiogenesis of circulating endothelial progenitor cells.
引文
[1]Asahara T,Murohara T,Sullivan A,etal.Isolation of putative progenitor endothelial cells for angiogenesis.Science.1997,275(5302):964-967
[2]Hur J,Yoon CH,Kim HS,etal.Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Tromb Vase Biol.2004,24(2):288-293
[3]Vasa M, Fichtlscherer S, Aicher A, etal. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.Circ Res.2001,89(1):E1-E7
[4]Kalka C,Masuda H,Takahashi T,etal. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA.2000,97(7):3422-3427
[5]van der Loo B, Fenton MJ, Erusalimsky JD. Cytochemical detection of a senescence-associated beta-galactosidase in endothelial and smooth muscle cells from human and rabbit blood vessels. Exp Cell Res.1998,241 (2):309-315
[6]Dimri GP, Lee X, Basile G, etal. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA.1995,92 (20): 9363-9367
[7]Minamino T, Miyauchi H, Yoshida T, etal. Endothelial cell senescence in human atherosclerosis:role of telomere in endothelial dysfunction. Circulation. 2002,105(13):1541-1544
[8]Hill JM, Zalos G, Halcox JP,etal. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med.2003,348(7):593-600
[9]Twickler TB, Dallinga-Thie GM,Cohn JS,etal. Elevated remnant-like particle cholesterol concentration:a characteristic feature of the atherogenic lipoprotein phenotype. Circulation.2004,109(16):1918-1925
[10]Imke C,Rodriguez BL,Grove JS,etal. Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart study. Arterioscler Thromb Vase Biol.2005,25(8):1718-1722
[11]Kugiyama K, Doi H, Motoyama T,etal. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation.1998,97(25):2519-2526
[12]Doi H, Kugiyama K, Oka H, etal. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redoxsensitive mechanism. Circulation.2000,102(6):670-676
[13]Twickler TB,Dallinga-Thie GM,Visseren FL, etal. Induction of postprandial inflammatory response in adult onset growth hormone deficiency is related to plasma remnant-like particle-cholesterol concentration. J Clin Endocrinol Metab.2003, 88(3):1228-1233
[14]Kawakami A, Tani M, Chiba T, etal. Pitavastatin inhibits remnant lipoprotein-induced macrophage foam cell formation through ApoB48 receptor-dependent mechanism. Arterioscler Thromb Vase Biol.2005,25(2):424-429
[15]Shin HK,Kim YK,and Kim KY, etal. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectinlike oxidized low-density lipoprotein receptor-1 activation:prevention by cilostazol. Circulation.2004,109(8):1022-1028
[16]Liu L, Zhao SP, GaoM, etal. Vitamin C preserves endothelial function in patients with coronary heart disease after a high-fat meal. Clin Cardiol.2002,25(5):219-224
[17]Zhao SP,Liu L,Cheng YC,etal. Xuezhikang, an extract of cholestin,protects endothelial function through anti-inflammatory and lipid-lowering mechanisms in patients with coronary heart disease. Circulation.2004,110(8):915-920
[18]Schmidt D, Breymann C, Weber A,etal. Umbilical cord blood derived end-othelial progenitor cells for tissue engineering of vascular grafts. Ann Thorac Surg.2004,78(6):2094-2098
[19]Rehman J, Li J, Orschell CM, etal. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation.2003,107(8):1164-1169
[20]Ingram DA,Caplice NM,Yoder MC.Unresolved questions,changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood.2005,106(5): 1525-1531
[21]Rafii S, Heissig B, Hattori K. Efficient mobilization and recruitment of marrow derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther.2002,9(10):631-641
[22]Schmeisser A, Garlichs CD, Zhang H,etal. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res.2001,49(3):671-680
[23]Kanayasu-Toyoda T,Yamaguchi T,Oshizawa T,etal. CD31 (PECAM-1)-bright cells derived from AC133-positive cells in human peripheral blood as endothelial precursor cells. J Cell Physiol.2003,195(1):119-129
[24]Imanishi T, Hano T, Nishio I. Angiotensin Ⅱ accelerates endothelial progenitor cell senescence through induction of oxidative stress.J Hypertens.2005,23(1):97-104
[25]Imanishi T, Hano T, Sawamura T, etal. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol.2004,31(7):407-413
[26]Nakajima K,Saito T,Tamura A,etal. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoa-ffinity mixed gels. Clin Chim Acta.1993,223(l-2):53-71
[27]Funada J, Sekiya M, Hamada M, etal. Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction. Circ J.2002,66(2):127-132
[28]Ceriello A, Assaloni R, Da Ros R, etal. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction,oxidative stress, and inflammation in type 2 diabetic patients. Circulation.2005,111(19):2518-2524
[29]Assmus B,Urbich C,Aicher A,etal. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res.2003,92(9):1049-1055
[30]Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med.2005,56:79-101
[31]Sk'ora J,Biegus J,Pupka A,etal. Molecular basics of angiogenesis. Postepy Hig Med Dosw.2006,60:410-415
[32]Feugier P,JoDY,Shieh JH, etal. Ex vivo expansion of stem and progenitor cells in coculture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin,c-kit ligand, and Flt-3 ligand. J Hematother Stem Cell Res.2002,11(1):127-138
[33]Zhu JH,Chen JZ, Wang XX,etal. Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells. J Mol Cell Cardiol.2006,40(5): 648-652
[34]Doi H,Kugiyama K,Ohgushi M,etal. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis. 1998,137(2):341-349
[35]Goulter AB, Avella MA, Elliott J,etal.Chylomicron-remnant like particles inhibit receptor-mediated endothelium-dependent vasorelaxation in pig coronary arteries. Clin Sci (Lond).2002,103(5):451-460
[36]Ohara N,Takeichi S, NaitoY, etal. Remnant-like particles from subjects who died of coronary artery disease suppress NO synthase activity and attenuate endothelium-dependent vasorelaxation. Clin Chim Acta.2003,338(1-2):151-156
[37]Doi H, Kugiyama K, Ohgushi M, etal. Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation. Arterioscler Thromb Vasc Biol.1999,19(8):1918-1924
[38]Vasa M, Breitschopf K, Zeiher AM, etal. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res.2000,87(7):540-542
[39]Ma FX, Zhou B, Chen Z, etal. Oxidized low-density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res.2006,47(6):1227-1237
[40]Chen YH, Lin SJ, Lin FY, etal. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes.2007,56(6):1559-1568
[41]Le Boeuf F,Houle F,Huot J.Regulation of vascular endothelial growth factor receptor 2-mediated phosphorylation of focal adhesion kinase by heat shock protein 90 and Src kinase activities. J Biol Chem.2004,279(37):39175-39185
[42]Werner N, Junk S,Laufs U,etal.Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res.2003,93(2):e17-24
[43]Vasa M, Fichtlscherer S, Adler K,etal. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation.2001,103(24):2885-2890
[44]Urbich C, Dernbach E, Zeiher AM,etal.Double-edged role of statins in angiogenesis signaling.Circ Res.2002,90(6):737-744
[45]Llevadot J, Murasawa S, Kureishi Y, etal. HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J Clin Invest.2001, 108(3):399-405
[46]Dimmeler S, Aicher A, Vasa M,etal.HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. J Clin Invest.2001,108(3):391-397
[47]Walter DH, Rittig K, Bahlmann FH, etal. Statin therapy accelerates reendothelialization:a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation.2002,105(25):3017-3024
[48]Spyridopoulos I,Haendeler J,Urbich C, etal.Statins enhance migratory capacityby upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation.2004,110(19):3136-3142
[49]Ballard VL, Sharma A, Duignan I. Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization. FASEB J.2006,20(6):717-719
[50]Murakami M, Goto T, Saito Y,etal. The inhibitory effect of simvastatin on growth in malignant gliomas--with special reference to its local application with fibrin glue spray in vivo..Int J Oncol.2001,19(3):525-531
[51]Anand BS,Velez M. Assessment of correlation between serum titers of hepatitis C virus and severity of liver disease. World J Gastroenterol.2004,10(16):2409-2411
[52]Murayama T, Tepper OM, Silver M, etal. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol.2002,30(8):967-972
[53]Suzuki T,Nishida M,Futami S, etal.Neoendothelialization after peripheral blood stem cell transplantation in humans:a case report of a Tokaimura nuclearaccident victim. Cardiovasc Res.2003,58(2):487-492
[54]Pape SA, Skouras CA, Byrne PO. An audit of the use of laser Dopplerimaging (LDI) in the assessment of burns of intermediate depth.Burns.2001,27(3):233-239
[55]Thorfinn J, Sjoberg F, Lidman D. Sitting pressure and perfusion of buttock skin in paraplegic and tetraplegic patients, and in healthy subjects:a comparative study. Scand J Plast Reconstr Surg Hand Surg.2002,36(5):279-283
[56]Arora S, Pomposelli F, LoGerfo FW, etal.Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization.J Vasc Surg.2002,35(3):501-505
[57]Seifalian AM, Chaloupka K, Parbhoo SP. Laser Doppler perfusion imaging--a new technique for measuring breast skin blood flow.Int J Microcirc Clin Exp. 1995,15(3):125-130
[58]Imanishi T,Hano T,Nishio I.Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells.Hypertens Res.2005,28(3):263-271
[59]Kobayashi K, Imanishi T, Akasaka T. Endothelial progenitor cell differentiation and senescence in an angiotensin Ⅱ-infusion rat model. Hypertens Res.2006,29(6): 449-455
[60]Babuccu O, Peksoy I, Hosnuter M, etal. Evaluation by scintigraphy of hindlimb ischemia in a rat model. J Reconstr Microsurg.2004,20(5):405-410
[61]Lee SH, Wolf PL, Escudero R, etal. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med.2000,342(9):626-633
[62]Iwaguro H,Yamaguchi J,Kalka C,etal.Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation.2002, 105(6):732-738
[63]Kobayashi K, Kondo T, Inoue N,etal. Combination of in vivo angiopoietin-1gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis. Arterioscler Thromb Vasc Biol.2006,26(7):1465-1472
[64]Kureishi Y,Luo Z,Shiojima I, etal. The HMG-CoA reduetase inhibitor simvastatin actirates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med.2000,6(9):1004-1010
[65]Harris MB,Blackstone MA,Sood SG,etal.Acute activation and phosphoryhtionof endothelial nitric oxide synthase by HMC-CoA reductase inhibitors.Am J Physiol Heart Circ Physiol.2004,287(2):H560-566
[66]Matsuno H,Takei M,Hayashi H,etal. Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries.J Cardiovase Pharmacol. 2004,43(3):333-340
[67]Urbich C,Dernbach E,Zeiher AM,etal. Double-edged role of stafins in angiogenesis signaling.Circ Res.2002,90(6):737-744
[68]LIevadot J, Murasawa S, Kureishi Y,etal. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest. 2001,108(3):399-405
[69]Kusuyama T,Omura T,Ni shlya D,etal. The effects of HMG-CoA reductase inhibitor on vascular progenitor cells. J Pharmacol Sci.2006,101(4):344-349
[70]Vincent L,Chen W,Hong I, etal. Inhibition of endothelial cell migration by cerivastatin,an HMG-CoA reduetase inhibitor:contribution to its anti-angiogenic effect. FEBS Lett.2001,495(3):159-166
[71]Asakage M,Tsuno NH,Kitayama J,etal.3-Hydroxy-3-methylglutaryl-eoenzyme A reductase inhibitor(pravastatin)inhibits endothelial cell proliferation dependent on G1 cell cycle arrest. Anticancer Drugs.2004,15(6):625-632
[72]Vincent L,Albanese P,Bompais H,etal. Insights in the molecular mechanisms of the anti-angiogenic effect of an inhibitor of 3-hydroxy-3-methylglutaryl coe-nzyme A reductase. Thromb Haemost.2003,89(3):530-537
[73]Weis M, Heesehen C, Glassford AJ,etal. Stains have biphasic effects on angiogenesis. Circulation.2002,105(6):739-745
[74]Bartel DP. MicroRNAs:genomics, biogenesis, mechanism, and function.Cell. 2004,116 (2):281-297
[75]Pasquinelli AE,Reinhart BJ,Slack F, etal.Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature.2000,408 (6808):86-89
[76]Zhang B, Pan X, Cannon CH,etal. Conservation and divergence of plant microRNA genes. Plant J.2006,46(2):243-259
[77]Hatfield SD, Shcherbata HR, Fischer KA, etal. Stem cell division is regulated by the microRNA pathway. Nature.2005,435 (7044):974-978
[78]Poy MN, Eliasson L, Krutzfeldt J, etal. A pancreatic islet-specific micr-oRNA regulates insulin secretion.Nature.2004,432 (7014):226-230
[79]Esau C,Davis S,Murray SF, etal. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab.2006,3 (2):87-98
[80]Berezikov E,Guryev V,van de Belt J, etal. Phylogenetic shadowing and computational identification of human microRNA genes. Cell.2005,120 (1):21-24
[81]Eric A Miska. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev.2005,15(5):563-568
[82]Johnson SM, Grosshans H, Shingara J, etal. RAS is regulated by the let-7 microRNA family. Cell.2005,120(5):635-647
[83]Daubman S.MicroRNAs in angiogenesis and vascular smooth muscle cell function. Circ Res.2010,106(3):423-425
[84]Khorram O, Han G, Bagherpour R,etal. The Effect of Maternal Undernutrition On Vascular Expression of Micro and Messenger RNA in Newborn and Aging Offspring. Am J Physiol Regul Integr Comp Physiol.2010 Mar 3 [Epub ahead of print]
[85]Griffiths-Jones S, Gocock RJ, van Dongen S, etal. miRBase:microRNA sequences, targets and gene nomenclature. Nucleic Acids Res.2006,34(Database issue):D140-D144
[86]Ambros V,Bartel B,Bartel DP,etal.A uniform system for microRNA annotation. RNA.2003,9(3):277-279
[87]Kim VN, MicroRNA biogenesis:coordinated cropping and dicing. Nat Rev Mol Cell Biol.2005,6(5):376-385
[88]Liu CG, Calin GA,Meloon B.An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA.20 04,101(26):9740-9744
[89]Chendrimada TP,Gregory RI, Kumaraswamy E, etal. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing.Nature.2005,436 (7051):740-744
[90]Garzon R, Fabbri M, Cimmino A, etal. MicroRNA expression and function in cancer. Trends Mol Med.2006,12(12):580-587
[91]Lewis BP, urge CB,Bartel DP.Conserved seed paining, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.Cell. 2005,120(1):15-20
[92]Suarez Y, Fernandez-Hernando C,Pober JS,etal. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Re.2007,100 (8):1164-1173
[93]Chen Y, Gorski DH. Regulation of angiogenesis through a microRNA(miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood.2008, 111(3):1217-1226
[94]Kulshreshtha R, Ferracin M, Wojcik SE, etal. A microRNA signature of hypoxia. Mol Cell Biol.2007,27(5):1859-1867
[95]Fasanaro P, D'Alessandra Y, Di Stefano V, etal. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine-kinase ligand Ephrin-A3.J Biol Chem.2008,283(23):15878-15883
[96]Landmesser U,Engberding N,Bahlmann FH,etal. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function,and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation.2004,110(14):1933-1939
[97]Schoolmeesters A, Eklund T, Leake D, etal. Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoSOne.2009,4(5):e5605.
[98]Jiang S,Zhang HW,Lu MH,etal. MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene. Cancer Res. 2010 Mar 30; [Epub ahead of print]
[99]Suh MR,Lee Y,Kim JY,etal. Human embryonic stem cells express a unique set of microRNAs.Dev Biol.2004,270(2):488-498
[100]Poliseno L, Pitto L, Simili M, etal. The proto-oncogene LRF is under post-transcriptional control of MiR-20a:implications for senescence. PLoS One. 2008,3(7):e2542.
[101]Mudhasani R,Zhu Z, Hutvagner G,etal. Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells. J Cell Biol.2008,181 (7):1055-1063
[1]Op den Buijs J, Musters M, Verrips T, et al. Mathematical modeling of vascular endothelial layer maintenance:the role of endothelial cell division, progenitor cell homing, and telomere shortening. Am J Physiol Heart Circ Physiol.2004,287(6): H2651-2658
[2]Hill JM, Zalos G, Halcox JP, etal. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med.2003,348(7):593-600
[3]Schmidt-Lucke C, Rossig L, Fichtlscherer S,et al.Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events:proof of concept for the clinical importance of endogenous vascular repair. Circulation.2005,111:2981-2987
[4]Khakoo AY,Finkel T.Endothelial progenitor cells. Annu Rev Med 2005,56:79-101
[5]Skora J, Biegus J, Pupka A, et al.Molecular basics of angiogenesis.Postepy Hig Med Dosw.2006,60:410-415
[6]Zhu J,Wang X,et al. Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia. Arch Med Res.2006, 37(4):484-489
[7]Imanishi T, Hano T, Sawamura T,et al.Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol.2004,31(7):407-413
[8]Zhu JH, Chen JZ, et al. Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells. J Mol Cell Cardiol.2006,40(5):648-652
[9]Isabelle G, Mary K, et al. Vascular smooth muscle cell senescence in atherosclerosis.Cardiovasc Res.2006,72(1):9-17
[10]Imanishi T, Hano T, Nishio I.Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress.J Hypertens.2005,23(1):97-104
[11]Ooi TC, Cousins M, Ooi DS, et al. Postprandial remnant-like lipoproteins in hypertriglyceridemia. J Clin Endocrinol Metab.2001,86(7):3134-3142
[12]Oi K, Shimokawa H, Hirakawa Y, et al. Postprandial increase in plasma concentrations of remnant-like particles:an independent risk factor for restenosis after percutaneous coronary intervention. J Cardiovasc Pharmacol.2004.44(l):66-73
[13]Ishikawa T. Postprandial lipemia as an atherosclerotic risk factor and fat tolerance test. Nippon Rinsho.1999,57(12):2668-2672
[14]Funada J, Sekiya M, Hamada M, et al. Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction. Circ J.2002,66(2):127-132
[15]Saidi Y, Sich D, Camproux A, etal. Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia. Metabolism.1999,48(1):60-67
[16]Luc G, Fievet C, Arveiler D, etal. Apolipoproteins C-Ⅲ and E in apoB-and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction:the ECTIM study. Etude Cas Temoins sur 'Infarctus du Myocarde. J Lipid Res.1996,37(3):508-517
[17]Cohn JS,Marcoux C,Davignon J.Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins.Arterioscler Thromb Vasc Biol.1999,19(10):2474-2486
[18]Tsai MY, Georgopoulos A, Otvos JD,etal.Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load. Clin.Chem.2004.50:1201-1204.
[19]Nakajima K, Okazaki M, Tanaka A,et al.Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apoB-100 and apoA-I.J Clin Ligand Assay.1996,19(3):177-178
[20]Bittner V,Tripputi M,Hsia J,etal. Remnant-like lipoproteins,hormone therapy, and angiographic and clinical outcomes:The Women's Angiographic Vitamin& Estrogen Trial. Am Heart J.2004,148(2):293-299
[21]Leary ET,Wang T,Baker DJ,etal.Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma. Clin. Chem.1998,44(12):2490-2498
[22]Devaraj S,Vega G,Lange R,etal.Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease. Am J Med.1998, 104(5):445-450
[23]Rall SC, Mahley RW.The role of apolipoprotein E genetic variants in lipoprotein disorders. J Intern Med.1992,231(6):653-659
[24]Zhang SH,Reddick RL,Piedrahita JA,etal. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science.1992,258(5081):468-471
[25]Qiao J H, Tripathi J,Mishra NK et al.Role of macrphage colonystimulating fact or in herosclerosis:studies of osteopetrotic etroticmicelAm J Pathol.1997,150:1687
[26]Shireman PK, Pearce WH. Endothelial cell function:biologic and physiologic functions in health and disease. AJR Am J Roentgenol.1996,166(1):7-13
[27]Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation.2002,105(5):546-549
[28]Furumoto K, Inoue E, Nagao N,etal. Age-dependent telomere shortening is slowed down by enrichment of intracellular vitamin C via suppression of oxidative stress. Life Sci.1998,63(11):935-948
[29]Reiske HR, Zhao J, Han DC,etal. Analysis of FAK-associated signaling pathways in the regulation of cell cycle progression.FEBS Lett.2000,486(3):275-280
[30]Twickler TB, Dallinga-Thie GM,Cohn JS,etal. Elevated remnant-like particle cholesterol concentration:a characteristic feature of the atherogenic lipoprotein phenotype. Circulation.2004,109(16):1918-1925
[31]Liu L, Wen T, Zheng XY,etal. Remnant like particles accelerate endothelial progenitor cells senescence and induce cellular dysfunction via an oxidative mechanism. Atherosclerosis.2009,202(2):405-414
[32]Doi H, Kugiyama K, Oka H, etal. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation.2000,102(6):670-676
[33]Goulter AB, Avella MA, Elliott J,etal. Chylomicron-remnant-like particles inhibit receptor-mediated endothelium-dependent vasorelaxation in pig coronary arteries. Clin Sci (Lond).2002,103(5):451-460
[34]Ohara N,Takeichi S,Naito Y,etal. Remnant-like particles from subjects who died of coronary artery disease suppress NO synthase activity and attenuate endothelium dependent vasorelaxation. Clin Chem Acta.2003,338(1-2):151-156
[35]Kawakami A, Tanaka A, Nakajima K, etal. Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions. Circ Res.2002,91(3):263-271
[36]Rutledge JC,Woo MM, Rezai AA,etal. Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products. Circ Res.1997,80(6):819-828
[37]Yamazaki M, Uchiyama S,Xiong Y,etal. Effect of remnant-like particle on hear induced platelet activation and its inhibition by antiplatelet agents.Thromb Res.2005,115(3):211-218
[38]Kawakami A,Tanaka A,Chiba T,etal.Remnant lipoprotein induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation. Circulation.2003,108(21):2679-2688
[39]Oi K,Shimokawa H,Hiroki J,et al. Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase. Arterioscler Thromb Vasc Biol.2004,24(5):918-922
[40]Mamo JC, Proctor SD, Smith D. Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma. Atherosclerosis.1998,141 Suppl 1:S63-69
[41]Proctor SD,Pabla CK, J. C. L. Mamo. Arterial uptake of chylomicrons and low density lipoproteins in insulin deficient rats and rabbits. Atherosclerosis. 1997,134:314
[42]Yla-Herttuala,S.O.Jaakkola,C.Ehnholm,etal.Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic inti-ma. J. Lipid Res.1988,29:563-572
[43]Nakul-Aquaronne D, Bayle J, Frelin C.Coexpression of endothelial markers and CD14 by cytokine mobilized CD34+ cells under angiogenic stimulation. Cardiovasc Res.2003,57(3):816-23.
[44]Asahara T, Murohara T, Sullivan A, etal.Isoladon of putative progenitor endothelial cells for angingenesls.Science.1997,275(5302):964-967
[45]Murayama T, Tepper OM, Silver M, etal.Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol.2002,30(8):967-972
[46]Kocher AA, Schuster MD, Szabolcs MJ,etal. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte Apoptosis, reduces remodeling and improves cardiac function. Nat Med.2001, 7(4):430-436
[47]Kalka C,Masuda H,Takahashi T,etal.Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA,2000,97(7):3422-3427
[48]op den Buijs J, van den Bosch PP, Musters MW,etal. Mathematical modeling confirms the length-dependency of telomere shortening. Mech Ageing Dev. 2004,125(6):437-444
[49]Vasa M, Breitschopf K, Zeiher AM,etal. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res.2000,87(7):540-542
[50]Breitschopf K, Zeiher AM, Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett.2001,493(1):21-25
[51]Le Boeuf F, Houle F, Huot J. Regulation of vascular endothelial growth factor receptor 2-mediated phosphorylation of focal adhesion kinase by heat shock protein 90 and Src kinase activities. J Biol Chem.2004,279(37):39175-39185
[52]Koshida R, Rocic P, Saito S,et al. Role of focal adhesion kinase in flow-induced dilation of coronary arterioles. Arterioscler Thromb Vasciol.2005,25(12):2548-2553
[53]Nakamura T,Takano H, Umetani K, etal.Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. Atherosclerosis.2005,181(2):321-327
[54]Perrotta I,Brunelli E,Sciangula A,etal.Inducible and endothelial nitric oxide synthase expression in human atherogenesis:an immunohistochemical and ultrastructural study.Cardiovasc Pathol.2009,18(6):361-368
[55]Liu L, Zhao SP, Gao M,etal.Vitamin C preserves endothelial function in patients with coronary heart disease after a high-fat meal.Clin Cardiol.2002,25(5):219-224
[56]Roberts CK, Barnard RJ,Sindhu RK,etal. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism.2006,55(7):928-934
[57]Donato AJ, Eskurza I, Silver AE, et al. Direct evidence of endothelial oxidative stress with aging in humans:relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ Res.2007,100(11):1659-1666
[58]Liao JK.Statins:potent vascular anti-inflammatory agents. Int J Clin Pract Suppl.2004,Oct(143):41-48
[59]John S,Schneider MP,Delles C,etal. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.Am Heart J.2005,149(3):473
[60]Schulze F, Lenzen H, Hanefeld C,etal.Asymmetric dimethylarginine is an independent risk factor for coronary heart disease:results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study.Am Heart J.2006,152(3):493.el-e8
[61]Nagaoka T, Hein TW,Yoshida A,etal.Simvastatin elicits dilation of isolated porcine retinal arterioles:role of nitric oxide and mevalonate-rho kinase pathways. Invest Ophthalmol Vis Sci.2007,48(2):825-832
[62]Li D, Mehta JL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells:evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vase Biol.2000,20(4):1116-1122
[63]Dimmeler S,Aicher A,Vasa M,etal.HMG-CoA-reductase inhibitors(statins) increase endothelial progenitor cells via the PI3 kinase/Akt pathway.J Clin Invest. 2001,108(3):391-397
[64]Llevadot J, Murasawa S, Kureishi Y,etal. HMG-CoA reductase inhibitor mobilizes bone-marrow derived endothelial progenitor cells.J Clin Invest.2001,10 8(3):399-405
[65]Urbich C, Dernbach E, Zeiher AM,etal.Double-edged role of statins in angiogenesis signaling.Circ Res.2002,90(6):737-744
[66]Vasa M, Fichtlscherer S, Adler K,etal. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation.2001,103(24):2885-2890
[67]Kureishi Y,Luo Z,Shiojima I, etal. The HMG-CoA reduetase inhibitor simvastatin actirates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Nat Med.2000,6(9):1004-1010
[68]Harris MB,Blackstone MA,Sood SG,etal.Acute activation and phosphoryhtion of endothelial nitric oxide synthase by HMC-CoA reductase inhibitors. Am J Physiol Heart Circ Physiol.2004,287(2):H560-566
[69]Matsuno H,Takei M,Hayashi H,etal. Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries.J Cardiovase Pharmacol. 2004,43(3):333-340
[70]Urbich C,Dernbach E,Zeiher AM,etal. Double-edged role of stafins in angiogenesis signaling.Circ Res.2002,90(6):737-744
[71]Bao XM,Wu CF,Lu GP.Atorvastatin inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells. Acta Pharmacol Sin.2010.31(4):476-484
[72]Imanishi T, Hano T, Sawamura T,etal.Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction.Clin Exp Pharmacol Physiol.2004.31(7):407-413
[73]Matsumura M, Fukuda N, Kobayashi N,etal.Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats. J Atheroscler Thromb.2009,16(4):319-26
[2]Hur J,Yoon CH,Kim HS,etal.Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Tromb Vase Biol.2004,24(2):288-293
[3]Vasa M, Fichtlscherer S, Aicher A, etal. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.Circ Res.2001,89(1):E1-E7
[4]Kalka C,Masuda H,Takahashi T,etal. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA.2000,97(7):3422-3427
[5]van der Loo B, Fenton MJ, Erusalimsky JD. Cytochemical detection of a senescence-associated beta-galactosidase in endothelial and smooth muscle cells from human and rabbit blood vessels. Exp Cell Res.1998,241 (2):309-315
[6]Dimri GP, Lee X, Basile G, etal. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA.1995,92 (20): 9363-9367
[7]Minamino T, Miyauchi H, Yoshida T, etal. Endothelial cell senescence in human atherosclerosis:role of telomere in endothelial dysfunction. Circulation. 2002,105(13):1541-1544
[8]Hill JM, Zalos G, Halcox JP,etal. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med.2003,348(7):593-600
[9]Twickler TB, Dallinga-Thie GM,Cohn JS,etal. Elevated remnant-like particle cholesterol concentration:a characteristic feature of the atherogenic lipoprotein phenotype. Circulation.2004,109(16):1918-1925
[10]Imke C,Rodriguez BL,Grove JS,etal. Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart study. Arterioscler Thromb Vase Biol.2005,25(8):1718-1722
[11]Kugiyama K, Doi H, Motoyama T,etal. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation.1998,97(25):2519-2526
[12]Doi H, Kugiyama K, Oka H, etal. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redoxsensitive mechanism. Circulation.2000,102(6):670-676
[13]Twickler TB,Dallinga-Thie GM,Visseren FL, etal. Induction of postprandial inflammatory response in adult onset growth hormone deficiency is related to plasma remnant-like particle-cholesterol concentration. J Clin Endocrinol Metab.2003, 88(3):1228-1233
[14]Kawakami A, Tani M, Chiba T, etal. Pitavastatin inhibits remnant lipoprotein-induced macrophage foam cell formation through ApoB48 receptor-dependent mechanism. Arterioscler Thromb Vase Biol.2005,25(2):424-429
[15]Shin HK,Kim YK,and Kim KY, etal. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectinlike oxidized low-density lipoprotein receptor-1 activation:prevention by cilostazol. Circulation.2004,109(8):1022-1028
[16]Liu L, Zhao SP, GaoM, etal. Vitamin C preserves endothelial function in patients with coronary heart disease after a high-fat meal. Clin Cardiol.2002,25(5):219-224
[17]Zhao SP,Liu L,Cheng YC,etal. Xuezhikang, an extract of cholestin,protects endothelial function through anti-inflammatory and lipid-lowering mechanisms in patients with coronary heart disease. Circulation.2004,110(8):915-920
[18]Schmidt D, Breymann C, Weber A,etal. Umbilical cord blood derived end-othelial progenitor cells for tissue engineering of vascular grafts. Ann Thorac Surg.2004,78(6):2094-2098
[19]Rehman J, Li J, Orschell CM, etal. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation.2003,107(8):1164-1169
[20]Ingram DA,Caplice NM,Yoder MC.Unresolved questions,changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood.2005,106(5): 1525-1531
[21]Rafii S, Heissig B, Hattori K. Efficient mobilization and recruitment of marrow derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther.2002,9(10):631-641
[22]Schmeisser A, Garlichs CD, Zhang H,etal. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res.2001,49(3):671-680
[23]Kanayasu-Toyoda T,Yamaguchi T,Oshizawa T,etal. CD31 (PECAM-1)-bright cells derived from AC133-positive cells in human peripheral blood as endothelial precursor cells. J Cell Physiol.2003,195(1):119-129
[24]Imanishi T, Hano T, Nishio I. Angiotensin Ⅱ accelerates endothelial progenitor cell senescence through induction of oxidative stress.J Hypertens.2005,23(1):97-104
[25]Imanishi T, Hano T, Sawamura T, etal. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol.2004,31(7):407-413
[26]Nakajima K,Saito T,Tamura A,etal. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoa-ffinity mixed gels. Clin Chim Acta.1993,223(l-2):53-71
[27]Funada J, Sekiya M, Hamada M, etal. Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction. Circ J.2002,66(2):127-132
[28]Ceriello A, Assaloni R, Da Ros R, etal. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction,oxidative stress, and inflammation in type 2 diabetic patients. Circulation.2005,111(19):2518-2524
[29]Assmus B,Urbich C,Aicher A,etal. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res.2003,92(9):1049-1055
[30]Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med.2005,56:79-101
[31]Sk'ora J,Biegus J,Pupka A,etal. Molecular basics of angiogenesis. Postepy Hig Med Dosw.2006,60:410-415
[32]Feugier P,JoDY,Shieh JH, etal. Ex vivo expansion of stem and progenitor cells in coculture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin,c-kit ligand, and Flt-3 ligand. J Hematother Stem Cell Res.2002,11(1):127-138
[33]Zhu JH,Chen JZ, Wang XX,etal. Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells. J Mol Cell Cardiol.2006,40(5): 648-652
[34]Doi H,Kugiyama K,Ohgushi M,etal. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis. 1998,137(2):341-349
[35]Goulter AB, Avella MA, Elliott J,etal.Chylomicron-remnant like particles inhibit receptor-mediated endothelium-dependent vasorelaxation in pig coronary arteries. Clin Sci (Lond).2002,103(5):451-460
[36]Ohara N,Takeichi S, NaitoY, etal. Remnant-like particles from subjects who died of coronary artery disease suppress NO synthase activity and attenuate endothelium-dependent vasorelaxation. Clin Chim Acta.2003,338(1-2):151-156
[37]Doi H, Kugiyama K, Ohgushi M, etal. Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation. Arterioscler Thromb Vasc Biol.1999,19(8):1918-1924
[38]Vasa M, Breitschopf K, Zeiher AM, etal. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res.2000,87(7):540-542
[39]Ma FX, Zhou B, Chen Z, etal. Oxidized low-density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res.2006,47(6):1227-1237
[40]Chen YH, Lin SJ, Lin FY, etal. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes.2007,56(6):1559-1568
[41]Le Boeuf F,Houle F,Huot J.Regulation of vascular endothelial growth factor receptor 2-mediated phosphorylation of focal adhesion kinase by heat shock protein 90 and Src kinase activities. J Biol Chem.2004,279(37):39175-39185
[42]Werner N, Junk S,Laufs U,etal.Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res.2003,93(2):e17-24
[43]Vasa M, Fichtlscherer S, Adler K,etal. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation.2001,103(24):2885-2890
[44]Urbich C, Dernbach E, Zeiher AM,etal.Double-edged role of statins in angiogenesis signaling.Circ Res.2002,90(6):737-744
[45]Llevadot J, Murasawa S, Kureishi Y, etal. HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J Clin Invest.2001, 108(3):399-405
[46]Dimmeler S, Aicher A, Vasa M,etal.HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. J Clin Invest.2001,108(3):391-397
[47]Walter DH, Rittig K, Bahlmann FH, etal. Statin therapy accelerates reendothelialization:a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation.2002,105(25):3017-3024
[48]Spyridopoulos I,Haendeler J,Urbich C, etal.Statins enhance migratory capacityby upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation.2004,110(19):3136-3142
[49]Ballard VL, Sharma A, Duignan I. Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization. FASEB J.2006,20(6):717-719
[50]Murakami M, Goto T, Saito Y,etal. The inhibitory effect of simvastatin on growth in malignant gliomas--with special reference to its local application with fibrin glue spray in vivo..Int J Oncol.2001,19(3):525-531
[51]Anand BS,Velez M. Assessment of correlation between serum titers of hepatitis C virus and severity of liver disease. World J Gastroenterol.2004,10(16):2409-2411
[52]Murayama T, Tepper OM, Silver M, etal. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol.2002,30(8):967-972
[53]Suzuki T,Nishida M,Futami S, etal.Neoendothelialization after peripheral blood stem cell transplantation in humans:a case report of a Tokaimura nuclearaccident victim. Cardiovasc Res.2003,58(2):487-492
[54]Pape SA, Skouras CA, Byrne PO. An audit of the use of laser Dopplerimaging (LDI) in the assessment of burns of intermediate depth.Burns.2001,27(3):233-239
[55]Thorfinn J, Sjoberg F, Lidman D. Sitting pressure and perfusion of buttock skin in paraplegic and tetraplegic patients, and in healthy subjects:a comparative study. Scand J Plast Reconstr Surg Hand Surg.2002,36(5):279-283
[56]Arora S, Pomposelli F, LoGerfo FW, etal.Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization.J Vasc Surg.2002,35(3):501-505
[57]Seifalian AM, Chaloupka K, Parbhoo SP. Laser Doppler perfusion imaging--a new technique for measuring breast skin blood flow.Int J Microcirc Clin Exp. 1995,15(3):125-130
[58]Imanishi T,Hano T,Nishio I.Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells.Hypertens Res.2005,28(3):263-271
[59]Kobayashi K, Imanishi T, Akasaka T. Endothelial progenitor cell differentiation and senescence in an angiotensin Ⅱ-infusion rat model. Hypertens Res.2006,29(6): 449-455
[60]Babuccu O, Peksoy I, Hosnuter M, etal. Evaluation by scintigraphy of hindlimb ischemia in a rat model. J Reconstr Microsurg.2004,20(5):405-410
[61]Lee SH, Wolf PL, Escudero R, etal. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med.2000,342(9):626-633
[62]Iwaguro H,Yamaguchi J,Kalka C,etal.Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation.2002, 105(6):732-738
[63]Kobayashi K, Kondo T, Inoue N,etal. Combination of in vivo angiopoietin-1gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis. Arterioscler Thromb Vasc Biol.2006,26(7):1465-1472
[64]Kureishi Y,Luo Z,Shiojima I, etal. The HMG-CoA reduetase inhibitor simvastatin actirates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med.2000,6(9):1004-1010
[65]Harris MB,Blackstone MA,Sood SG,etal.Acute activation and phosphoryhtionof endothelial nitric oxide synthase by HMC-CoA reductase inhibitors.Am J Physiol Heart Circ Physiol.2004,287(2):H560-566
[66]Matsuno H,Takei M,Hayashi H,etal. Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries.J Cardiovase Pharmacol. 2004,43(3):333-340
[67]Urbich C,Dernbach E,Zeiher AM,etal. Double-edged role of stafins in angiogenesis signaling.Circ Res.2002,90(6):737-744
[68]LIevadot J, Murasawa S, Kureishi Y,etal. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest. 2001,108(3):399-405
[69]Kusuyama T,Omura T,Ni shlya D,etal. The effects of HMG-CoA reductase inhibitor on vascular progenitor cells. J Pharmacol Sci.2006,101(4):344-349
[70]Vincent L,Chen W,Hong I, etal. Inhibition of endothelial cell migration by cerivastatin,an HMG-CoA reduetase inhibitor:contribution to its anti-angiogenic effect. FEBS Lett.2001,495(3):159-166
[71]Asakage M,Tsuno NH,Kitayama J,etal.3-Hydroxy-3-methylglutaryl-eoenzyme A reductase inhibitor(pravastatin)inhibits endothelial cell proliferation dependent on G1 cell cycle arrest. Anticancer Drugs.2004,15(6):625-632
[72]Vincent L,Albanese P,Bompais H,etal. Insights in the molecular mechanisms of the anti-angiogenic effect of an inhibitor of 3-hydroxy-3-methylglutaryl coe-nzyme A reductase. Thromb Haemost.2003,89(3):530-537
[73]Weis M, Heesehen C, Glassford AJ,etal. Stains have biphasic effects on angiogenesis. Circulation.2002,105(6):739-745
[74]Bartel DP. MicroRNAs:genomics, biogenesis, mechanism, and function.Cell. 2004,116 (2):281-297
[75]Pasquinelli AE,Reinhart BJ,Slack F, etal.Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature.2000,408 (6808):86-89
[76]Zhang B, Pan X, Cannon CH,etal. Conservation and divergence of plant microRNA genes. Plant J.2006,46(2):243-259
[77]Hatfield SD, Shcherbata HR, Fischer KA, etal. Stem cell division is regulated by the microRNA pathway. Nature.2005,435 (7044):974-978
[78]Poy MN, Eliasson L, Krutzfeldt J, etal. A pancreatic islet-specific micr-oRNA regulates insulin secretion.Nature.2004,432 (7014):226-230
[79]Esau C,Davis S,Murray SF, etal. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab.2006,3 (2):87-98
[80]Berezikov E,Guryev V,van de Belt J, etal. Phylogenetic shadowing and computational identification of human microRNA genes. Cell.2005,120 (1):21-24
[81]Eric A Miska. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev.2005,15(5):563-568
[82]Johnson SM, Grosshans H, Shingara J, etal. RAS is regulated by the let-7 microRNA family. Cell.2005,120(5):635-647
[83]Daubman S.MicroRNAs in angiogenesis and vascular smooth muscle cell function. Circ Res.2010,106(3):423-425
[84]Khorram O, Han G, Bagherpour R,etal. The Effect of Maternal Undernutrition On Vascular Expression of Micro and Messenger RNA in Newborn and Aging Offspring. Am J Physiol Regul Integr Comp Physiol.2010 Mar 3 [Epub ahead of print]
[85]Griffiths-Jones S, Gocock RJ, van Dongen S, etal. miRBase:microRNA sequences, targets and gene nomenclature. Nucleic Acids Res.2006,34(Database issue):D140-D144
[86]Ambros V,Bartel B,Bartel DP,etal.A uniform system for microRNA annotation. RNA.2003,9(3):277-279
[87]Kim VN, MicroRNA biogenesis:coordinated cropping and dicing. Nat Rev Mol Cell Biol.2005,6(5):376-385
[88]Liu CG, Calin GA,Meloon B.An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA.20 04,101(26):9740-9744
[89]Chendrimada TP,Gregory RI, Kumaraswamy E, etal. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing.Nature.2005,436 (7051):740-744
[90]Garzon R, Fabbri M, Cimmino A, etal. MicroRNA expression and function in cancer. Trends Mol Med.2006,12(12):580-587
[91]Lewis BP, urge CB,Bartel DP.Conserved seed paining, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.Cell. 2005,120(1):15-20
[92]Suarez Y, Fernandez-Hernando C,Pober JS,etal. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Re.2007,100 (8):1164-1173
[93]Chen Y, Gorski DH. Regulation of angiogenesis through a microRNA(miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood.2008, 111(3):1217-1226
[94]Kulshreshtha R, Ferracin M, Wojcik SE, etal. A microRNA signature of hypoxia. Mol Cell Biol.2007,27(5):1859-1867
[95]Fasanaro P, D'Alessandra Y, Di Stefano V, etal. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine-kinase ligand Ephrin-A3.J Biol Chem.2008,283(23):15878-15883
[96]Landmesser U,Engberding N,Bahlmann FH,etal. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function,and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation.2004,110(14):1933-1939
[97]Schoolmeesters A, Eklund T, Leake D, etal. Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoSOne.2009,4(5):e5605.
[98]Jiang S,Zhang HW,Lu MH,etal. MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene. Cancer Res. 2010 Mar 30; [Epub ahead of print]
[99]Suh MR,Lee Y,Kim JY,etal. Human embryonic stem cells express a unique set of microRNAs.Dev Biol.2004,270(2):488-498
[100]Poliseno L, Pitto L, Simili M, etal. The proto-oncogene LRF is under post-transcriptional control of MiR-20a:implications for senescence. PLoS One. 2008,3(7):e2542.
[101]Mudhasani R,Zhu Z, Hutvagner G,etal. Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells. J Cell Biol.2008,181 (7):1055-1063
[1]Op den Buijs J, Musters M, Verrips T, et al. Mathematical modeling of vascular endothelial layer maintenance:the role of endothelial cell division, progenitor cell homing, and telomere shortening. Am J Physiol Heart Circ Physiol.2004,287(6): H2651-2658
[2]Hill JM, Zalos G, Halcox JP, etal. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med.2003,348(7):593-600
[3]Schmidt-Lucke C, Rossig L, Fichtlscherer S,et al.Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events:proof of concept for the clinical importance of endogenous vascular repair. Circulation.2005,111:2981-2987
[4]Khakoo AY,Finkel T.Endothelial progenitor cells. Annu Rev Med 2005,56:79-101
[5]Skora J, Biegus J, Pupka A, et al.Molecular basics of angiogenesis.Postepy Hig Med Dosw.2006,60:410-415
[6]Zhu J,Wang X,et al. Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia. Arch Med Res.2006, 37(4):484-489
[7]Imanishi T, Hano T, Sawamura T,et al.Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol.2004,31(7):407-413
[8]Zhu JH, Chen JZ, et al. Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells. J Mol Cell Cardiol.2006,40(5):648-652
[9]Isabelle G, Mary K, et al. Vascular smooth muscle cell senescence in atherosclerosis.Cardiovasc Res.2006,72(1):9-17
[10]Imanishi T, Hano T, Nishio I.Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress.J Hypertens.2005,23(1):97-104
[11]Ooi TC, Cousins M, Ooi DS, et al. Postprandial remnant-like lipoproteins in hypertriglyceridemia. J Clin Endocrinol Metab.2001,86(7):3134-3142
[12]Oi K, Shimokawa H, Hirakawa Y, et al. Postprandial increase in plasma concentrations of remnant-like particles:an independent risk factor for restenosis after percutaneous coronary intervention. J Cardiovasc Pharmacol.2004.44(l):66-73
[13]Ishikawa T. Postprandial lipemia as an atherosclerotic risk factor and fat tolerance test. Nippon Rinsho.1999,57(12):2668-2672
[14]Funada J, Sekiya M, Hamada M, et al. Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction. Circ J.2002,66(2):127-132
[15]Saidi Y, Sich D, Camproux A, etal. Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia. Metabolism.1999,48(1):60-67
[16]Luc G, Fievet C, Arveiler D, etal. Apolipoproteins C-Ⅲ and E in apoB-and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction:the ECTIM study. Etude Cas Temoins sur 'Infarctus du Myocarde. J Lipid Res.1996,37(3):508-517
[17]Cohn JS,Marcoux C,Davignon J.Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins.Arterioscler Thromb Vasc Biol.1999,19(10):2474-2486
[18]Tsai MY, Georgopoulos A, Otvos JD,etal.Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load. Clin.Chem.2004.50:1201-1204.
[19]Nakajima K, Okazaki M, Tanaka A,et al.Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apoB-100 and apoA-I.J Clin Ligand Assay.1996,19(3):177-178
[20]Bittner V,Tripputi M,Hsia J,etal. Remnant-like lipoproteins,hormone therapy, and angiographic and clinical outcomes:The Women's Angiographic Vitamin& Estrogen Trial. Am Heart J.2004,148(2):293-299
[21]Leary ET,Wang T,Baker DJ,etal.Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma. Clin. Chem.1998,44(12):2490-2498
[22]Devaraj S,Vega G,Lange R,etal.Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease. Am J Med.1998, 104(5):445-450
[23]Rall SC, Mahley RW.The role of apolipoprotein E genetic variants in lipoprotein disorders. J Intern Med.1992,231(6):653-659
[24]Zhang SH,Reddick RL,Piedrahita JA,etal. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science.1992,258(5081):468-471
[25]Qiao J H, Tripathi J,Mishra NK et al.Role of macrphage colonystimulating fact or in herosclerosis:studies of osteopetrotic etroticmicelAm J Pathol.1997,150:1687
[26]Shireman PK, Pearce WH. Endothelial cell function:biologic and physiologic functions in health and disease. AJR Am J Roentgenol.1996,166(1):7-13
[27]Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation.2002,105(5):546-549
[28]Furumoto K, Inoue E, Nagao N,etal. Age-dependent telomere shortening is slowed down by enrichment of intracellular vitamin C via suppression of oxidative stress. Life Sci.1998,63(11):935-948
[29]Reiske HR, Zhao J, Han DC,etal. Analysis of FAK-associated signaling pathways in the regulation of cell cycle progression.FEBS Lett.2000,486(3):275-280
[30]Twickler TB, Dallinga-Thie GM,Cohn JS,etal. Elevated remnant-like particle cholesterol concentration:a characteristic feature of the atherogenic lipoprotein phenotype. Circulation.2004,109(16):1918-1925
[31]Liu L, Wen T, Zheng XY,etal. Remnant like particles accelerate endothelial progenitor cells senescence and induce cellular dysfunction via an oxidative mechanism. Atherosclerosis.2009,202(2):405-414
[32]Doi H, Kugiyama K, Oka H, etal. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation.2000,102(6):670-676
[33]Goulter AB, Avella MA, Elliott J,etal. Chylomicron-remnant-like particles inhibit receptor-mediated endothelium-dependent vasorelaxation in pig coronary arteries. Clin Sci (Lond).2002,103(5):451-460
[34]Ohara N,Takeichi S,Naito Y,etal. Remnant-like particles from subjects who died of coronary artery disease suppress NO synthase activity and attenuate endothelium dependent vasorelaxation. Clin Chem Acta.2003,338(1-2):151-156
[35]Kawakami A, Tanaka A, Nakajima K, etal. Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions. Circ Res.2002,91(3):263-271
[36]Rutledge JC,Woo MM, Rezai AA,etal. Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products. Circ Res.1997,80(6):819-828
[37]Yamazaki M, Uchiyama S,Xiong Y,etal. Effect of remnant-like particle on hear induced platelet activation and its inhibition by antiplatelet agents.Thromb Res.2005,115(3):211-218
[38]Kawakami A,Tanaka A,Chiba T,etal.Remnant lipoprotein induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation. Circulation.2003,108(21):2679-2688
[39]Oi K,Shimokawa H,Hiroki J,et al. Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase. Arterioscler Thromb Vasc Biol.2004,24(5):918-922
[40]Mamo JC, Proctor SD, Smith D. Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma. Atherosclerosis.1998,141 Suppl 1:S63-69
[41]Proctor SD,Pabla CK, J. C. L. Mamo. Arterial uptake of chylomicrons and low density lipoproteins in insulin deficient rats and rabbits. Atherosclerosis. 1997,134:314
[42]Yla-Herttuala,S.O.Jaakkola,C.Ehnholm,etal.Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic inti-ma. J. Lipid Res.1988,29:563-572
[43]Nakul-Aquaronne D, Bayle J, Frelin C.Coexpression of endothelial markers and CD14 by cytokine mobilized CD34+ cells under angiogenic stimulation. Cardiovasc Res.2003,57(3):816-23.
[44]Asahara T, Murohara T, Sullivan A, etal.Isoladon of putative progenitor endothelial cells for angingenesls.Science.1997,275(5302):964-967
[45]Murayama T, Tepper OM, Silver M, etal.Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol.2002,30(8):967-972
[46]Kocher AA, Schuster MD, Szabolcs MJ,etal. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte Apoptosis, reduces remodeling and improves cardiac function. Nat Med.2001, 7(4):430-436
[47]Kalka C,Masuda H,Takahashi T,etal.Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA,2000,97(7):3422-3427
[48]op den Buijs J, van den Bosch PP, Musters MW,etal. Mathematical modeling confirms the length-dependency of telomere shortening. Mech Ageing Dev. 2004,125(6):437-444
[49]Vasa M, Breitschopf K, Zeiher AM,etal. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res.2000,87(7):540-542
[50]Breitschopf K, Zeiher AM, Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett.2001,493(1):21-25
[51]Le Boeuf F, Houle F, Huot J. Regulation of vascular endothelial growth factor receptor 2-mediated phosphorylation of focal adhesion kinase by heat shock protein 90 and Src kinase activities. J Biol Chem.2004,279(37):39175-39185
[52]Koshida R, Rocic P, Saito S,et al. Role of focal adhesion kinase in flow-induced dilation of coronary arterioles. Arterioscler Thromb Vasciol.2005,25(12):2548-2553
[53]Nakamura T,Takano H, Umetani K, etal.Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. Atherosclerosis.2005,181(2):321-327
[54]Perrotta I,Brunelli E,Sciangula A,etal.Inducible and endothelial nitric oxide synthase expression in human atherogenesis:an immunohistochemical and ultrastructural study.Cardiovasc Pathol.2009,18(6):361-368
[55]Liu L, Zhao SP, Gao M,etal.Vitamin C preserves endothelial function in patients with coronary heart disease after a high-fat meal.Clin Cardiol.2002,25(5):219-224
[56]Roberts CK, Barnard RJ,Sindhu RK,etal. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism.2006,55(7):928-934
[57]Donato AJ, Eskurza I, Silver AE, et al. Direct evidence of endothelial oxidative stress with aging in humans:relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ Res.2007,100(11):1659-1666
[58]Liao JK.Statins:potent vascular anti-inflammatory agents. Int J Clin Pract Suppl.2004,Oct(143):41-48
[59]John S,Schneider MP,Delles C,etal. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.Am Heart J.2005,149(3):473
[60]Schulze F, Lenzen H, Hanefeld C,etal.Asymmetric dimethylarginine is an independent risk factor for coronary heart disease:results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study.Am Heart J.2006,152(3):493.el-e8
[61]Nagaoka T, Hein TW,Yoshida A,etal.Simvastatin elicits dilation of isolated porcine retinal arterioles:role of nitric oxide and mevalonate-rho kinase pathways. Invest Ophthalmol Vis Sci.2007,48(2):825-832
[62]Li D, Mehta JL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells:evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vase Biol.2000,20(4):1116-1122
[63]Dimmeler S,Aicher A,Vasa M,etal.HMG-CoA-reductase inhibitors(statins) increase endothelial progenitor cells via the PI3 kinase/Akt pathway.J Clin Invest. 2001,108(3):391-397
[64]Llevadot J, Murasawa S, Kureishi Y,etal. HMG-CoA reductase inhibitor mobilizes bone-marrow derived endothelial progenitor cells.J Clin Invest.2001,10 8(3):399-405
[65]Urbich C, Dernbach E, Zeiher AM,etal.Double-edged role of statins in angiogenesis signaling.Circ Res.2002,90(6):737-744
[66]Vasa M, Fichtlscherer S, Adler K,etal. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation.2001,103(24):2885-2890
[67]Kureishi Y,Luo Z,Shiojima I, etal. The HMG-CoA reduetase inhibitor simvastatin actirates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Nat Med.2000,6(9):1004-1010
[68]Harris MB,Blackstone MA,Sood SG,etal.Acute activation and phosphoryhtion of endothelial nitric oxide synthase by HMC-CoA reductase inhibitors. Am J Physiol Heart Circ Physiol.2004,287(2):H560-566
[69]Matsuno H,Takei M,Hayashi H,etal. Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries.J Cardiovase Pharmacol. 2004,43(3):333-340
[70]Urbich C,Dernbach E,Zeiher AM,etal. Double-edged role of stafins in angiogenesis signaling.Circ Res.2002,90(6):737-744
[71]Bao XM,Wu CF,Lu GP.Atorvastatin inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells. Acta Pharmacol Sin.2010.31(4):476-484
[72]Imanishi T, Hano T, Sawamura T,etal.Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction.Clin Exp Pharmacol Physiol.2004.31(7):407-413
[73]Matsumura M, Fukuda N, Kobayashi N,etal.Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats. J Atheroscler Thromb.2009,16(4):319-26